The most important forces shaping commercial real estate in 2026 are not totally theoretical.
They’re already scheduled.
After surviving 2025, a majority of Bisnow readers are ready to get more in the deal mix in ‘26.
The reactions online revealed a Chinese society divided: Some saw what happened in Venezuela as a playbook for seizing Taiwan, while others warned about ideological rigidity.
The law firm representing embattled developer Meyer Chetrit wants out. Baron Samson has accused members of the Chetrit family of failing to cooperate with counsel and not paying legal bills, with the law firm allegedly no longer able to trust information from its clients. It’s unusual to see these sorts of public accusations from an attorney about their client, but nothing about Chetrit’s past year has been typical. The developer is battling a $132 million judgement owed to an entity of Maverick Real Estate Partners after a foreclosure case, as well as criminal charges of tenant harassment. “[P]romises of cooperation […]
This article originally appeared on The Real Deal. Click here to read the full story.
Two pending deals at Vlad Doronin’s Aman New York crowned Manhattan’s luxury market in the final days of 2025. Deals for two condos at the luxury hotel-condo conversion at 730 Fifth Avenue snagged the No. 1 and No. 2 spots among 13 deals inked for homes in Manhattan asking $4 million or more between Dec. 29th and Jan. 4, according to Olshan Realty’s weekly report. The total was slightly below the decade average of 15 contracts signed during the week of the New Year, but in line with the number of deals inked ahead of the Christmas holiday. The priciest […]
This article originally appeared on The Real Deal. Click here to read the full story.
Mack Real Estate Group took control of a Hudson Yards development site long tied up in litigation with the Chetrit Group. Mack closed on a $94 million title transfer for a vacant parcel at 545 West 37th Street, PincusCo reported. Mack acquired the site from a Chetrit affiliate in a deal that closed Dec. 18 and was recorded Jan. 2. The transaction values the site at about $543 per buildable square foot, based on 172,00 square feet of unused development rights and no existing built space. Mack and Chetrit did not immediately respond to requests for comment from The Real […]
This article originally appeared on The Real Deal. Click here to read the full story.
Mayor Zohran Mamdani came out swinging against “bad landlords” shortly after taking office. The new mayor’s first actions included naming a frequent adversary of city landlords to an office dedicated to tenant rights. He also announced that the city will “intervene” in a bankruptcy case that will decide the fate of thousands of rent-stabilized apartments. During Mamdani’s first 100 days in office, the administration will host hearings for tenants to sound off about their landlords and living conditions, dubbed “Rental Ripoff” hearings. These actions underscore a point the mayor made during his inauguration address, that he will not moderate or […]
This article originally appeared on The Real Deal. Click here to read the full story.
SL Green got the ball rolling with its plan to sell $2.5 billion worth of property. The REIT sold a minority stake in the office building at 100 Park Avenue to Rockpoint at a $425 million valuation, The Real Deal has learned. The Marc Holliday-led company bought a 49 percent stake in the 900,000-square-foot building from its partner Prudential in December 2024, at a $360 million valuation, and then injected some of its own equity into the property before flipping the interest to Rockpoint before the start of the new year. The 1940s-era office building just south of Grand Central […]
This article originally appeared on The Real Deal. Click here to read the full story.
The second-largest U.S. oil company, which kept pumping oil in the country after others left, could find it relatively easy to expand its operations if the political conditions there improve.
Bank OZK sold a $265M construction loan backing a largely empty life sciences campus in California, a rare departure in strategy for a lender that has been reluctant to sell distressed debt.